新型冠状病毒疫苗接种策略经济学评价研究进展

目的:了解国内外新型冠状病毒疫苗（新冠疫苗）接种策略相关的经济学评价研究进展，为开展基于中国真实世界证据疫苗接种策略经济学评价提供参考。方法:对中英文数据库2020年1月至2021年12月的文献进行检索，纳入新冠疫苗接种策略经济学评价研究，并对相关文献进行叙述性整合。结果:共纳入16篇英文文献（含3篇综述），发现无论品...

Progress in research of economic evaluation of COVID-19 vaccination strategies

Objective To understand the research progresses of economic evaluation of COVID-19 vaccination strategies both at home and abroad, and provide reference for the economic evaluation of COVID-19 vaccination strategies using real word data in China. Methods Literature retrieval was conducted for related papers published from January, 2020 to December, 2021 in Chinese and English databases, including the economic evaluation of COVID-19 vaccination, and the results of the related literatures were narratively integrated. Results A total of 16 English literatures (including 3 reviews) were included, and it was found that the COVID-19 vaccination was cost-effective or cost-saving regardless of the vaccine types, while the cost-effectiveness in different population and under different vaccination dose strategies varied due to vaccine efficacy, vaccine price, duration of natural immunity, duration of vaccination campaign, vaccine supply, and vaccination pace. Conclusions China lacks suitable evidences of economic evaluation of COVID-19 vaccination strategies based on real-world data in the context of long-term epidemic. Therefore, further researches of suitable strategies of booster COVID-19 vaccination are needed.